Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease.
about
Bone marrow derived stem cells for the treatment of end-stage liver diseaseAutologous bone marrow-derived cells in the treatment of liver disease patientsConcise review: bone marrow autotransplants for liver disease?Systematic review: the effects of autologous stem cell therapy for patients with liver diseaseBone marrow cells obtained from cirrhotic rats do not improve function or reduce fibrosis in a chronic liver disease model.Bone marrow-derived stromal cell therapy in cirrhosis: clinical evidence, cellular mechanisms, and implications for the treatment of hepatocellular carcinoma.Outcomes of autologous bone marrow mononuclear cell transplantation in decompensated liver cirrhosis.Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver diseaseCellular therapy for liver diseaseStem cells in clinical practice: applications and warnings.REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stemBone marrow-derived mesenchymal stem cell therapy for decompensated liver cirrhosis: a meta-analysis.Autologous bone marrow stem cells in the treatment of chronic liver diseaseNatural Killer Cells-Produced IFN-γ Improves Bone Marrow-Derived Hepatocytes Regeneration in Murine Liver Failure Model.Murine Sca1(+)Lin(-) bone marrow contains an endodermal precursor population that differentiates into hepatocytes.The use of cellular technologies in treatment of liver pathologies.The hematopoietic system in the context of regenerative medicine.Liver stem cells: a scientific and clinical perspective.Bone marrow mononuclear cells have neurovascular tropism and improve diabetic neuropathy.Current status of stem cell therapy for liver diseases.Human hepatocyte transplantation: state of the art.Prospects for stem cell transplantation in the treatment of hepatic disease.Autologous hematopoietic stem cell transplantation in 48 patients with end-stage chronic liver diseases.Autologous bone marrow cell infusion therapy for liver cirrhosis patients.Interplay between bone marrow and liver in the pathogenesis of hepatic fibrosis.Timeline for development of autologous bone marrow infusion (ABMi) therapy and perspective for future stem cell therapy.Liver regenerative medicine: advances and challenges.Stem cells in liver regeneration and their potential clinical applications.Role of stem cells in repair of liver injury: experimental and clinical benefit of transferred stem cells on liver failure.Immunological basis of stem cell therapy in liver diseases.Bone marrow cell-based regenerative therapy for liver cirrhosis.Cell-based therapy approaches: the hope for incurable diseases.Use of stem cells for liver diseases-current scenario.Bone marrow stem-cell therapy for genetic and chronic liver diseases.Cell transplantation as a non-invasive strategy for treating liver fibrosis.Progress in stem cell-based therapy for liver disease.Long-Term Follow-Up of Patients After Autologous Bone Marrow Cell Infusion for Decompensated Liver Cirrhosis.Liver stem cells derived from the bone marrow and umbilical cord blood.Hepatic regenerative potential of mouse bone marrow very small embryonic-like stem cells.Randomized trial of autologous bone marrow mesenchymal stem cells transplantation for hepatitis B virus cirrhosis: regulation of Treg/Th17 cells.
P2860
Q26850412-A5C839ED-5DFC-4084-9C5E-5D6FC202AF8EQ26863284-5B505524-F0DE-4145-B232-DC6549C24F3EQ27010009-90D5C6DC-2497-4921-919E-88E3379B2053Q27024968-216392F1-963F-4452-9241-FB7A5D2F0DD6Q33521757-B82B9E18-2182-4ADF-9540-0D792EC1044EQ33818431-93A69DA8-4D19-444D-8ECF-8205A7E90F4CQ33887116-6FBF0BB4-0CA0-4B3B-922C-079D133CFFA0Q33900601-32FAE937-71C1-41C4-B4A2-5E1671775241Q34418973-C3E80653-9464-4E3B-B75F-3327A21BB95BQ34552765-7B57DC26-8DB8-436B-A18A-9B942C89120CQ35203746-B534E0ED-2EE0-4FB2-A4A7-FD6A2F588196Q35336227-20143893-C125-45B1-B835-0F8B5A38C844Q35550572-D2F4416F-D03C-4F1A-A289-C0D597C46CEDQ36033943-EAC1DFFB-8AF7-4182-9C7C-857D3EA8D90CQ36356962-16B4634A-E2E4-403E-A9FF-00BC282D32E0Q36379723-77916EA6-1A3A-4ADE-9858-C3315E70AEF0Q36627127-3175C250-C98B-4D13-A489-7CA0C65F5981Q37138044-DE5596C2-6D4E-4479-A6E3-32EFB9DDCDEBQ37352703-57C8C1DF-B288-47FC-A535-55BD11BB73FFQ37574218-F842984B-9DA5-4DA1-8D3C-E12044EC1E68Q37599928-C63A8CFF-2F99-4F17-B4EE-146AA92EDE41Q37768108-5D85E669-4326-4F71-A7ED-83ED96737731Q37768554-FDA486CA-4DDB-4EE6-81A2-8FC8BD657614Q37772790-001C9645-338C-4216-B541-637DC425C3F1Q37992675-E1D3909E-7245-49D4-B95F-EB9291FF9388Q38001330-5AC89AED-74BC-4214-BD37-D3136BBCE535Q38008810-C0CF5706-D909-42B6-9126-93D707E3EABDQ38092746-E2356580-C49F-4857-9974-D5D83143AF10Q38159684-6EA6DF82-09D9-4473-BEB2-A9FC0EE75529Q38223210-17FDA19F-5F8F-4B4D-8122-7E3E160227F4Q38252582-FE678D3D-60BF-40AB-AA76-C8639AF76F9AQ38265206-C850FA46-17A4-4523-8373-89BC2F986E2AQ38371445-D03B0FF1-C74D-494A-8415-2664CFF224CDQ38552426-CFF15AAE-D12F-41F1-A5C8-092D8EAD9442Q38675565-74A45EEB-34DD-4BA5-9A8C-F8DC3CB7C998Q38836460-15C564E3-1A19-4E41-A720-568495B988D5Q39000508-F62BA7C3-4CA9-4802-95AE-4432A33C9813Q39634151-C9F0F289-B0EB-4D4D-9525-0D19F0417637Q41643401-589790BB-2175-450F-955E-D0EDB24FFA61Q42211604-E215432E-46B4-4B1D-B991-30386207A505
P2860
Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease.
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Feasibility and safety of auto ...... dvanced chronic liver disease.
@ast
Feasibility and safety of auto ...... dvanced chronic liver disease.
@en
Feasibility and safety of auto ...... dvanced chronic liver disease.
@nl
type
label
Feasibility and safety of auto ...... dvanced chronic liver disease.
@ast
Feasibility and safety of auto ...... dvanced chronic liver disease.
@en
Feasibility and safety of auto ...... dvanced chronic liver disease.
@nl
prefLabel
Feasibility and safety of auto ...... dvanced chronic liver disease.
@ast
Feasibility and safety of auto ...... dvanced chronic liver disease.
@en
Feasibility and safety of auto ...... dvanced chronic liver disease.
@nl
P2093
P2860
P356
P1476
Feasibility and safety of auto ...... advanced chronic liver disease
@en
P2093
Andre Castro Lyra
André Goyanna Pinheiro Silva
Augusto César de Andrade Mota
Eduardo Lorens Braga
Luiz Flavio Maia da Silva
Luiz Guilherme Costa Lyra
Marcos Fraga Fortes
Milena Botelho Pereira Soares
Ricardo Ribeiro dos Santos
Sheilla A Oliveira
P2860
P304
P356
10.3748/WJG.V13.I7.1067
P407
P50
P577
2007-02-01T00:00:00Z